Compounds > 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride
Page last updated: 2024-09-04

2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and tak 044

2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with tak 044 in 1 studies

Compound Research Comparison

Studies
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)		Trials
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)		Recent Studies (post-2010)
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)		Studies
(tak 044)		Trials
(tak 044)		Recent Studies (post-2010) (tak 044)
100010582

Protein Interaction Comparison

ProteinTaxonomy2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride (IC50)tak 044 (IC50)
Endothelin-1 receptorHomo sapiens (human)0.0002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakura, T; Hayasi, J; Isogai, A; Kubota, S; Moriya, H; Shimizu, S; Takara, T; Watanabe, T; Yamaguchi, S1

Other Studies

1 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and tak 044

ArticleYear
Effects of the endothelin-1 receptor antagonist TAK-044 on pulmonary injury in discordant xenotransplantation.
    Transplantation proceedings, 2000, Volume: 32, Issue:5

    Topics: Animals; Endothelin Receptor Antagonists; Guinea Pigs; Heart Transplantation; Hydroxamic Acids; Lung; Peptides, Cyclic; Rats; Receptor, Endothelin A; Tacrolimus; Transplantation, Heterologous

2000